Affinity Asset Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-170,000
| Closed | -$3.68M | – | 73 |
|
|
2022
Q3 | $3.68M | Buy |
170,000
+100,000
| +143% | +$2.17M | 1.03% | 23 |
|
|
2022
Q2 | $1.97M | Sell |
70,000
-137,500
| -66% | -$3.86M | 0.83% | 21 |
|
|
2022
Q1 | $9.57M | Buy |
207,500
+90,000
| +77% | +$4.15M | 1.53% | 10 |
|
|
2021
Q4 | $9.88M | Buy |
117,500
+40,000
| +52% | +$3.36M | 3.59% | 5 |
|
|
2021
Q3 | $5.17M | Sell |
77,500
-64,918
| -46% | -$4.33M | 1.3% | 16 |
|
|
2021
Q2 | $7.58M | Buy |
142,418
+64,918
| +84% | +$3.45M | 2.71% | 7 |
|
|
2021
Q1 | $3.36M | Buy |
+77,500
| New | +$3.36M | 1.14% | 18 |
|